Search research articles
Contact Us
Filters
Showing results (241-250 of 311) with videos related to
Page
of 32
Sort By:
International Clinical Psychopharmacology
|
June 1, 1995
Trazodone treatment increases plasma prolactin concentrations in depressed patients
K Otani, N Yasui, S Kaneko, et al.
No Shinkei Geka. Neurological Surgery
|
June 1, 1991
[Treatment for serious cases of ruptured intracranial aneurysms with severe subarachnoid clot]
M Mizuno, N Yasui, A Suzuki, et al.
Therapeutic Drug Monitoring
|
August 1, 1997
Single-dose pharmacokinetics and pharmacodynamics of oral triazolam in relation to cytochrome P4502C19 (CYP2C19) activity
N Yasui, K Otani, T Ohkubo, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 14, 2000
Novel mutations of the cathepsin K gene in patients with pycnodysostosis and their characterization
Y Fujita, K Nakata, N Yasui, et al.
Neurologia Medico-Chirurgica
|
March 1, 1994
Serial transcranial Doppler flow velocity and cerebral blood flow measurements for evaluation of cerebral vasospasm after subarachnoid hemorrhage
M Mizuno, S Nakajima, T Sampei, et al.
The American Journal of Psychiatry
|
October 2, 2001
Association of the TaqI A polymorphism of the dopamine D(2) receptor gene with predisposition to neuroleptic malignant syndrome
A Suzuki, T Kondo, K Otani, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
June 16, 2001
Association between TaqI A dopamine D2 receptor polymorphism and therapeutic response to bromperidol: a preliminary report
A Suzuki, T Kondo, K Mihara, et al.
American Journal of Medical Genetics
|
May 16, 2001
Relationship between Taq1 A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidol
K Mihara, A Suzuki, T Kondo, et al.
European Journal of Clinical Pharmacology
|
March 19, 2005
Induction of the metabolism of etizolam by carbamazepine in humans
S Kondo, T Fukasawa, N Yasui-Furukori, et al.
European Journal of Clinical Pharmacology
|
July 3, 2004
Inhibition of the metabolism of etizolam by itraconazole in humans: evidence for the involvement of CYP3A4 in etizolam metabolism
K Araki, N Yasui-Furukori, T Fukasawa, et al.
Page
of 32
Search research articles
Search
Showing results (241-250 of 311) with videos related to
Sort By:
Page
of 32
International Clinical Psychopharmacology
|
June 1, 1995
Trazodone treatment increases plasma prolactin concentrations in depressed patients
K Otani, N Yasui, S Kaneko, et al.
No Shinkei Geka. Neurological Surgery
|
June 1, 1991
[Treatment for serious cases of ruptured intracranial aneurysms with severe subarachnoid clot]
M Mizuno, N Yasui, A Suzuki, et al.
Therapeutic Drug Monitoring
|
August 1, 1997
Single-dose pharmacokinetics and pharmacodynamics of oral triazolam in relation to cytochrome P4502C19 (CYP2C19) activity
N Yasui, K Otani, T Ohkubo, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 14, 2000
Novel mutations of the cathepsin K gene in patients with pycnodysostosis and their characterization
Y Fujita, K Nakata, N Yasui, et al.
Neurologia Medico-Chirurgica
|
March 1, 1994
Serial transcranial Doppler flow velocity and cerebral blood flow measurements for evaluation of cerebral vasospasm after subarachnoid hemorrhage
M Mizuno, S Nakajima, T Sampei, et al.
The American Journal of Psychiatry
|
October 2, 2001
Association of the TaqI A polymorphism of the dopamine D(2) receptor gene with predisposition to neuroleptic malignant syndrome
A Suzuki, T Kondo, K Otani, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
June 16, 2001
Association between TaqI A dopamine D2 receptor polymorphism and therapeutic response to bromperidol: a preliminary report
A Suzuki, T Kondo, K Mihara, et al.
American Journal of Medical Genetics
|
May 16, 2001
Relationship between Taq1 A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidol
K Mihara, A Suzuki, T Kondo, et al.
European Journal of Clinical Pharmacology
|
March 19, 2005
Induction of the metabolism of etizolam by carbamazepine in humans
S Kondo, T Fukasawa, N Yasui-Furukori, et al.
European Journal of Clinical Pharmacology
|
July 3, 2004
Inhibition of the metabolism of etizolam by itraconazole in humans: evidence for the involvement of CYP3A4 in etizolam metabolism
K Araki, N Yasui-Furukori, T Fukasawa, et al.
Page
of 32